Harvard Bioscience, Inc.
HBIO
$0.3769
-$0.013-3.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 18.00K | -4.80M | -2.93M | -4.69M | -1.82M |
| Total Depreciation and Amortization | 1.76M | 1.82M | 1.80M | 1.78M | 1.78M |
| Total Amortization of Deferred Charges | 98.00K | 89.00K | 70.00K | 70.00K | 70.00K |
| Total Other Non-Cash Items | 442.00K | 1.53M | 1.79M | 2.54M | 1.89M |
| Change in Net Operating Assets | -593.00K | 528.00K | -1.58M | 1.71M | 2.39M |
| Cash from Operations | 1.73M | -842.00K | -846.00K | 1.40M | 4.30M |
| Capital Expenditure | -301.00K | -880.00K | -818.00K | -645.00K | -830.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 0.00 |
| Other Investing Activities | -165.00K | -231.00K | 1.28M | 420.00K | -231.00K |
| Cash from Investing | -466.00K | -1.11M | 458.00K | -225.00K | -1.06M |
| Total Debt Issued | 0.00 | 3.25M | 3.05M | 2.50M | 1.00M |
| Total Debt Repaid | -1.00M | -1.00M | -3.05M | -3.52M | -3.25M |
| Issuance of Common Stock | 161.00K | 15.00K | 189.00K | 15.00K | 206.00K |
| Repurchase of Common Stock | -518.00K | 0.00 | -12.00K | -47.00K | -2.07M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -161.00K | -- | -- | -- |
| Cash from Financing | -1.36M | 2.10M | 177.00K | -1.06M | -4.12M |
| Foreign Exchange rate Adjustments | -363.00K | 370.00K | 4.00K | -151.00K | -183.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -461.00K | 521.00K | -207.00K | -28.00K | -1.06M |